<DOC>
	<DOCNO>NCT00852917</DOCNO>
	<brief_summary>The objective study compare analgesic efficacy safety Tramadol Once Day 100 , 200 , 300 mg Placebo</brief_summary>
	<brief_title>A Four-Arm Study Comparing Analgesic Efficacy Safety Tramadol Once Day 100 , 200 300 mg Versus Placebo Treatment Pain Due Osteoarthritis Knee ( With 7-Day Follow-up )</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Tramadol</mesh_term>
	<criteria>1 . Males Females age 4075 diagnosis moderate severe osteoarthritis knee , consistent ACR Clinical Classification Criteria Arthritis Knee : Current knee pain . Less 30 minute morning stiffness without crepitus active motion . Confirmation either arthroscopy radiologist 's report ( Xrays show osteophyte , joint space narrow subchondral bone sclerosis { eburnation } ) within five year prior entry study . 2 . CRP &lt; 8 ug/mL ( available local lab ) ESR &lt; 40 mm/hr . 3 . Total WOMAC ( Western Ontario McMaster University Osteoarthritis Index ) Pain Subscale Score &gt; 150 mm Baseline correspond moderate severe Osteoarthritis . 4 . Oral write language comprehension level sufficient comply protocol complete studyrelated material . 5 . REB approval write Informed Consent Form Spanish English sign dated patient Investigator , prior study participation . 1 . Known rheumatoid arthritis rheumatoid disease . 2 . Secondary arthritis i.e . follow : septic arthritis ; inflammatory joint disease ; gout ; pseudogout ; Paget 's disease ; joint fracture ; acromegaly ; fibromyalgia ; Wilson 's disease ; ochronosis ; haemochromatosis ; osteochondromatosis ; collagen gene mutation . 3 . Evidence effusion great 15 cc upon physical examination joint Baseline ( Visit 1 ) . 4 . BMI great equal 38 . 5 . Major illness , require hospitalization 3 month commencement screening period . 6 . Unwillingness stop take pain medication ( arthritis type pain ) unwilling stop take medication treatment OA . 7 . Previous failure discontinuation ( due adverse event ) tramadol HCl therapy . 8 . Treatment within last 3 week follow medication : monoamine oxidase inhibitor ; tricyclic antidepressant tricyclic compound ( e.g . cyclobenzaprine , promethazine ) ; neuroleptic ; selective serotonin reuptake inhibitor ; drug reduce seizure threshold . 9 . Treatment another investigational agent within last 30 day . 10 . A history seizure disorder Infantile Febrile Seizures . 11 . Previous current opioid dependency . 12 . Bowel disease cause malabsorption . 13 . Pregnancy lactate childbearing potential unwilling utilize medically approve method contraception participation clinical trial . 14 . Significant liver disease , define active hepatitis elevate liver enzymes &gt; 3 time upper boundary normal range . 15 . Significant renal disease , define creatinine clearance &lt; 30 mL/min estimate method Levey et al. , 1999 . 16 . Current substance abuse dependence , nicotine . 17 . Allergy adverse reaction tramadol structurally similar drug e.g . opiate . 18 . Any condition , opinion Investigators , would adversely affected patient 's ability complete study measure .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Pain due Osteoarthritis Knee</keyword>
</DOC>